3QBD’s vision is to provide the field of Women’s Healthcare with a new gynecologic diagnostic tool that will transform the health and well-being of women throughout the world. With the 3QBD solution, the patented VGTest, women can receive improved healthcare as their physicians diagnose within 60 seconds their Bacterial Vaginosis more accurately, more rapidly and with more precision – enabling correct immediate treatment.
Future development plans for 3QBD include expanding research further into the medical field, to detect additional infections and diseases, particularly in the field of oncology. Other applications are for food and livestock.
The Technology
IMS (Ion Mobility Spectrometry) Technology
3QBD’s technology is based on the well established and scientifically proven Ion Mobility Spectrometry (IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect the presence and type of infection.
Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial processes, are accompanied by the breakdown of amino-acids and production of biogenic amines. Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting through a gas bath under the influence of an electric field.
VGTest is a novel, patented device that uses IMS technology to diagnose the three most common forms of Vaginitis: bacterial vaginosis, candidiasis and trichomoniasis. The device works by measuring the biogenic amines in the sample that are present at elevated levels when infections are present with results within one minute. In addition the VGTest test spares the physician from having to perform the Amsel Test and “whiff tests” of vaginal fluid.
Company’s Keywords:
diagnostic, womens health, gynecology, bio device, biotechnology, ims, ion mobility spectrometry, medical, health
<4
<
<2000